Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer

Molecular and Cellular Proteomics

Volumn 11, Issue 7, 2012, Pages

  Warmoes, Marc ^a   Jaspers, Janneke E ^b   Pham, Thang V ^a   Piersma, Sander R ^a   Oudgenoeg, Gideon ^a   Massink, Maarten P G ^a   Waisfisz, Quinten ^a   Rottenberg, Sven ^b   Boven, Epie ^a   Jonkers, Jos ^b   Jimenez, Connie R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEOME; BRCA1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA REPAIR; FEMALE; GEL ELECTROPHORESIS; GENE EXPRESSION; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SEQUENCE HOMOLOGY; TANDEM MASS SPECTROMETRY; UPREGULATION; ANIMAL; BREAST TUMOR; EXPERIMENTAL NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MICROARRAY ANALYSIS; MORTALITY; MULTIGENE FAMILY; MUTATION; SURVIVAL;

ANIMALS; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA REPAIR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICROARRAY ANALYSIS; MULTIGENE FAMILY; MUTATION; NEOPLASM PROTEINS; PROTEIN INTERACTION MAPPING; PROTEOME; PROTEOMICS; SEQUENCE HOMOLOGY, AMINO ACID; SURVIVAL ANALYSIS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84861433356     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.013334     Document Type: Article

References (59)

1. van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (Pubitemid 34130608)
2. Turner, N. C., Reis-Filho, J. S. (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25, 5846-5853 (Pubitemid 44453440)
3. Jaspers, J. E., Rottenberg, S., and Jonkers, J. (2009) Therapeutic options for triple-negative breast cancers with defective homologous recombination. Biochim. Biophys. Acta 1796, 266-280
4. Gudmundsdottir, K., and Ashworth, A. (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25, 5864-5874 (Pubitemid 44453442)
5. Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., Lu, K., Schmutzler, R. K., Matulonis, U., Wickens, M., and Tutt, A. (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial. Lancet 376, 245-251
6. Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lønning, P., and Børresen-Dale, A. L. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A. 98, 10869-10874
7. Glas, A. M., Floore, A., Delahaye, L. J., Witteveen, A. T., Pover, R. C., Bakx, N., Lahti-Domenici, J. S., Bruinsma, T. J., Warmoes, M. O., Bernards, R., Wessels, L. F., and Van't Veer, L. J. (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7, 278
8. Jönsson, G., Staaf, J., Vallon-Christersson, J., Ringnér, M., Holm, K., Hegardt, C., Gunnarsson, H., Fagerholm, R., Strand, C., Agnarsson, B. A., Kilpivaara, O., Luts, L., Heikkilä, P., Aittomäki, K., Blomqvist, C., Loman, N., Malmström, P., Olsson, H., Johannsson, O. T., Arason, A., Nevanlinna, H., Barkardottir, R. B., and Borg, A. (2010) Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res. 12, R42
9. Joosse, S. A., Brandwijk, K. I., Mulder, L., Wesseling, J., Hannemann, J., and Nederlof, P. M. (2011) Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors. Genes Chromosomes Cancer 50, 71-81
10. Naderi, A., Teschendorff, A. E., Barbosa-Morais, N. L., Pinder, S. E., Green, A. R., Powe, D. G., Robertson, J. F., Aparicio, S., Ellis, I. O., Brenton, J. D., and Caldas, C. (2007) A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26, 1507-1516 (Pubitemid 46340809)
11. Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., Hiller, W., Fisher, E. R., Wickerham, D. L., Bryant, J., and Wolmark, N. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817-2826 (Pubitemid 40051905)
12. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (Pubitemid 35461656)
13. Vollebergh, M. A., Lips, E. H., Nederlof, P. M., Wessels, L. F., Schmidt, M. K., van Beers, E. H., Cornelissen, S., Holtkamp, M., Froklage, F. E., de Vries, E. G., Schrama, J. G., Wesseling, J., van, d.,V, van, T. H., de, B. M., Hauptmann, M., Rodenhuis, S., and Linn, S. C. (2012) An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. Ann. Oncol., 22, 1561-1570
14. Waddell, N., Arnold, J., Cocciardi, S., da Silva, L., Marsh, A., Riley, J., Johnstone, C. N., Orloff, M., Assie, G., Eng, C., Reid, L., Keith, P., Yan, M., Fox, S., Devilee, P., Godwin, A. K., Hogervorst, F. B., Couch, F., Grimmond, S., Flanagan, J. M., Khanna, K., Simpson, P. T., Lakhani, S. R., and Chenevix-Trench, G. (2010) Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res. Treat. 123, 661-677
15. Straver, M. E., Glas, A. M., Hannemann, J., Wesseling, J., van de Vijver, M. J., Rutgers, E. J., Vrancken Peeters, M. J., van Tinteren, H., Van't Veer, L. J., and Rodenhuis, S. (2010) The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer. Breast Cancer Res. Treat. 119, 551-558
16. Cardoso, F., Piccart-Gebhart, M., Van't Veer, L., and Rutgers, E. (2007) The MINDACT trial: The first prospective clinical validation of a genomic tool. Mol. Oncol. 1, 246-251 (Pubitemid 350181650)
17. Pavlou, M. P., Kulasingam, V., Sauter, E. R., Kliethermes, B., and Diamandis, E. P. (2010) Nipple aspirate fluid proteome of healthy females and patients with breast cancer. Clin. Chem. 56, 848-855
18. Xu, X., Qiao, M., Zhang, Y., Jiang, Y., Wei, P., Yao, J., Gu, B., Wang, Y., Lu, J., Wang, Z., Tang, Z., Sun, Y., Wu, W., and Shi, Q. (2010) Quantitative proteomics study of breast cancer cell lines isolated from a single patient: Discovery of TIMM17A as a marker for breast cancer. Proteomics 10, 1374-1390
19. Umar, A., Kang, H., Timmermans, A. M., Look, M. P., Meijer-van Gelder, M. E., den Bakker, M. A., Jaitly, N., Martens, J. W., Luider, T. M., Foekens, J. A., and Pasa-Tolić, L. (2009) Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol. Cell. Proteomics 8, 1278-1294
20. Lai, T. C., Chou, H. C., Chen, Y. W., Lee, T. R., Chan, H. T., Shen, H. H., Lee, W. T., Lin, S. T., Lu, Y. C., Wu, C. L., and Chan, H. L. (2010) Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J. Proteome Res. 9, 1302-1322
21. Celis, J. E., Gromov, P., Cabezón, T., Moreira, J. M., Ambartsumian, N., Sandelin, K., Rank, F., and Gromova, I. (2004) Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: A novel resource for biomarker and therapeutic target discovery. Mol. Cell. Proteomics 3, 327-344 (Pubitemid 38702087)
22. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., and Mann, M. (2010) Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat. Methods 7, 383-385
23. Becker, S., Cazares, L. H., Watson, P., Lynch, H., Semmes, O. J., Drake, R. R., and Laronga, C. (2004) Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann. Surg. Oncol. 11, 907-914 (Pubitemid 40486676)
24. Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F., Peterse, J. L., Berns, A., and Jonkers, J. (2007) Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 12111-12116 (Pubitemid 47185638)
25. Derksen, P. W., Liu, X., Saridin, F., van der Gulden, H., Zevenhoven, J., Evers, B., van Beijnum, J. R., Griffioen, A. W., Vink, J., Krimpenfort, P., Peterse, J. L., Cardiff, R. D., Berns, A., and Jonkers, J. (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437-449 (Pubitemid 44693469)
26. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858
27. Piersma, S. R., Fiedler, U., Span, S., Lingnau, A., Pham, T. V., Hoffmann, S., Kubbutat, M. H., and Jiménez, C. R. (2010) Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: Method evaluation, differential analysis, and verification in serum. J. Proteome Res. 9, 1913-1922
28. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658 (Pubitemid 37082259)
29. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392 (Pubitemid 35215372)
30. Pham, T. V., Piersma, S. R., Warmoes, M., and Jimenez, C. R. (2010) On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics 26, 363-369
31. Albrethsen, J., Knol, J. C., Piersma, S. R., Pham, T. V., de Wit, M., Mongera, S., Carvalho, B., Verheul, H. M., Fijneman, R. J., Meijer, G. A., and Jimenez, C. R. (2010) Subnuclear proteomics in colorectal cancer: Identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol. Cell. Proteomics 9, 988-1005
32. Sun, C. H., Kim, M. S., Han, Y., and Yi, G. S. (2009) COFECO: Composite function annotation enriched by protein complex data. Nucleic Acids Res. 37, W350-W355
33. Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C., Muller, J., Doerks, T., Julien, P., Roth, A., Simonovic, M., Bork, P., and von Mering, C. (2009) STRING 8: A global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37, D412-D416
34. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D., and Foekens, J. A. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679 (Pubitemid 40260888)
35. Wright, M. H., Calcagno, A. M., Salcido, C. D., Carlson, M. D., Ambudkar, S. V., and Varticovski, L. (2008) Brca1 breast tumors contain distinct CD44+/. Breast Cancer Res. 10, R10
36. Stuart-Harris, R., Caldas, C., Pinder, S. E., and Pharoah, P. (2008) Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 17, 323-334
37. Cordes, N. (2006) Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury. Cancer Lett. 242, 11-19
38. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., and Qin, J. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927-939 (Pubitemid 30253002)
39. Heale, J. T., Ball, A. R., Jr., Schmiesing, J. A., Kim, J. S., Kong, X., Zhou, S., Hudson, D. F., Earnshaw, W. C., and Yokomori, K. (2006) Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair. Mol. Cell 21, 837-848 (Pubitemid 43376133)
40. Lee, C. G., Hague, L. K., Li, H., and Donnelly, R. (2004) Identification of toposome, a novel multisubunit complex containing topoisomerase IIα. Cell Cycle 3, 638-647 (Pubitemid 40278210)
41. Osley, M. A., Tsukuda, T., and Nickoloff, J. A. (2007) ATP-dependent chromatin remodeling factors and DNA damage repair. Mutat. Res. 618, 65-80 (Pubitemid 46574743)
42. Konstantinopoulos, P. A., Spentzos, D., Karlan, B. Y., Taniguchi, T., Fountzilas, E., Francoeur, N., Levine, D. A., and Cannistra, S. A. (2010) Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J. Clin. Oncol. 28, 3555-3561
43. Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., Ashworth, A., Carmichael, J., Kaye, S. B., Schellens, J. H., and de Bono, J. S. (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 361, 123-134
44. Turner, N., Tutt, A., and Ashworth, A. (2004) Hallmarks of "BRCAness" in sporadic cancers. Nat. Rev. Cancer 4, 814-819
45. Manié, E., Vincent-Salomon, A., Lehmann-Che, J., Pierron, G., Turpin, E., Warcoin, M., Gruel, N., Lebigot, I., Sastre-Garau, X., Lidereau, R., Remenieras, A., Feunteun, J., Delattre, O., de Thé, H., Stoppa-Lyonnet, D., and Stern, M. H. (2009) High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res. 69, 663-671
46. Holstege, H., Joosse, S. A., van Oostrom, C. T., Nederlof, P. M., de Vries, A., and Jonkers, J. (2009) High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res. 69, 3625-3633
47. Gorski, J. J., James, C. R., Quinn, J. E., Stewart, G. E., Staunton, K. C., Buckley, N. E., McDyer, F. A., Kennedy, R. D., Wilson, R. H., Mullan, P. B., and Harkin, D. P. (2010) BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res. Treat. 122, 721-731
48. Helleday, T., Petermann, E., Lundin, C., Hodgson, B., and Sharma, R. A. (2008) DNA repair pathways as targets for cancer therapy. Nat. Rev. Cancer 8, 193-204 (Pubitemid 351301852)
49. Rottenberg, S., Jaspers, J. E., Kersbergen, A., van der Burg, E., Nygren, A. O., Zander, S. A., Derksen, P. W., de Bruin, M., Zevenhoven, J., Lau, A., Boulter, R., Cranston, A., O'Connor, M. J., Martin, N. M., Borst, P., and Jonkers, J. (2008) High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc. Natl. Acad. Sci. U.S.A. 105, 17079-17084
50. Zander, S. A., Kersbergen, A., van der Burg, E., de Water, N., van Tellingen, O., Gunnarsdottir, S., Jaspers, J. E., Pajic, M., Nygren, A. O., Jonkers, J., Borst, P., and Rottenberg, S. (2010) Sensitivity and acquired resistance of BRCA1: p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan. Cancer Res. 70, 1700-1710
51. Rottenberg, S., Nygren, A. O., Pajic, M., van Leeuwen, F. W., van, der, Heijden, I., van de Wetering, K., Liu, X., de Visser, K. E., Gilhuijs, K. G., van Tellingen, O., Schouten, J. P., Jonkers, J., and Borst, P. (2007) Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 12117-12122 (Pubitemid 47185639)
52. Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., Haffty, B. G., Tommiska, J., Blomqvist, C., Drapkin, R., Adams, D. J., Nevanlinna, H., Bartek, J., Tarsounas, M., Ganesan, S., and Jonkers, J. (2010) 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol. 17, 688-695
53. Bunting, S. F., Callén, E., Wong, N., Chen, H. T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., Xu, X., Deng, C. X., Finkel, T., Nussenzweig, M., Stark, J. M., and Nussenzweig, A. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141, 243-254
54. Cianfrocca, M., Goldstein, L. J. (2004) Prognostic and predictive factors in early-stage breast cancer. Oncologist 9, 606-616 (Pubitemid 39546402)
55. Sun, B., Zhang, S., Zhang, D., Li, Y., Zhao, X., Luo, Y., and Guo, Y. (2008) Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin. Cancer Res. 14, 7050-7059
56. Cha, S., Imielinski, M. B., Rejtar, T., Richardson, E. A., Thakur, D., Sgroi, D. C., and Karger, B. L. (2010) In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: Annotation by protein set enrichment analysis and gene ontology. Mol. Cell. Proteomics 9, 2529-2544
57. Mbeunkui, F., Metge, B. J., Shevde, L. A., and Pannell, L. K. (2007) Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J. Proteome Res. 6, 2993-3002 (Pubitemid 47310184)
58. Ou, K., Yu, K., Kesuma, D., Hooi, M., Huang, N., Chen, W., Lee, S. Y., Goh, X. P., Tan, L. K., Liu, J., Soon, S. Y., Bin Abdul Rashid, S., Putti, T. C., Jikuya, H., Ichikawa, T., Nishimura, O., Salto-Tellez, M., and Tan, P. (2008) Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. J. Proteome Res. 7, 1518-1528
59. Hochgräfe, F., Zhang, L., O'Toole, S. A., Browne, B. C., Pinese, M., Porta Cubas, A., Lehrbach, G. M., Croucher, D. R., Rickwood, D., Boulghourjian, A., Shearer, R., Nair, R., Swarbrick, A., Faratian, D., Mullen, P., Harrison, D. J., Biankin, A. V., Sutherland, R. L., Raftery, M. J., and Daly, R. J. (2010) Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Cancer Res. 70, 9391-9401